Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
66 studies found for:    Open Studies | "Acne Vulgaris"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Acne Vulgaris"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: S6G5T-3;   Drug: S6G5T-1;   Drug: S6G5T-5;   Drug: S6G5T-6;   Drug: S6G5T-7;   Drug: S6G5T-8
2 Recruiting Venus Versa Diamondpolar Applicator Treatment Followed by AC Dual Applicator Treatment for Facial Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Device: Venus Versa
3 Recruiting A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)
Condition: Acne Vulgaris
Interventions: Drug: CB-03-01 cream, 1%;   Drug: Vehicle cream
4 Recruiting A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)
Condition: Acne Vulgaris
Interventions: Drug: CB-03-01 cream, 1%;   Drug: Vehicle cream
5 Not yet recruiting TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Vehicle;   Drug: TSN2898
6 Recruiting Efficacy and Safety of CD5789 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: CD5789 50μg/g cream;   Drug: Placebo cream
7 Recruiting Double-Blind Efficacy and Safety of CD5789 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: CD5789 50µg/g Cream;   Drug: Placebo cream
8 Recruiting A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris
Condition: Facial Acne Vulgaris
Intervention: Device: Sebacia Microparticles
9 Not yet recruiting An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: cortexolone 17α-propionate
10 Recruiting Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne
Condition: Acne Vulgaris
Interventions: Drug: Sarecycline;   Drug: Placebo
11 Recruiting Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne
Condition: Acne Vulgaris
Interventions: Drug: Sarecycline;   Drug: Placebo
12 Recruiting A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
Condition: Acne Vulgaris
Interventions: Drug: FMX-101, 4% minocycline foam;   Drug: Vehicle Foam
13 Recruiting A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
Condition: Acne Vulgaris
Interventions: Drug: FMX-101, 4% minocycline foam;   Drug: Vehicle Foam
14 Recruiting Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Other: Feedback group;   Other: Non Feedback group
15 Recruiting Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Device: Sebacia microparticle and laser treatment;   Device: Vehicle and laser treatment
16 Recruiting Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Biological: B244;   Biological: Placebo
17 Recruiting BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: BPX-01 1% Minocycline Topical Gel;   Drug: BPX-01 2% Minocycline Topical Gel;   Drug: BPX-01 Vehicle Topical Gel
18 Recruiting Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Dapsone 5.0% Gel (SEEGPharm);   Other: Placebo;   Drug: Dapsone 5.0% Gel (Allergan)
19 Recruiting Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: dapsone gel
20 Not yet recruiting A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: IDP-120 Gel;   Drug: IDP-120 Component A;   Drug: IDP-120 Component B;   Drug: IDP-120 Vehicle Gel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.